218 related articles for article (PubMed ID: 34254296)
1. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma.
Bavle A; Tewari S; Sisson A; Chintagumpala M; Anderson M; Paulino AC
Pediatr Blood Cancer; 2018 Aug; 65(8):e27095. PubMed ID: 29693784
[TBL] [Abstract][Full Text] [Related]
3. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
[TBL] [Abstract][Full Text] [Related]
4. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
[TBL] [Abstract][Full Text] [Related]
5. Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
Liu IC; Holtzman AL; Rotondo RL; Indelicato DJ; Gururangan S; Cavaliere R; Carter B; Morris CG; Tavanaiepour D; Rutenberg MS
J Neurooncol; 2021 Jul; 153(3):467-476. PubMed ID: 34105033
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
[TBL] [Abstract][Full Text] [Related]
7. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
Ho ESQ; Barrett SA; Mullaney LM
Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
[TBL] [Abstract][Full Text] [Related]
8. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
[TBL] [Abstract][Full Text] [Related]
9. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.
Zhang R; Howell RM; Giebeler A; Taddei PJ; Mahajan A; Newhauser WD
Phys Med Biol; 2013 Feb; 58(4):807-23. PubMed ID: 23322160
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
Aldrich KD; Horne VE; Bielamowicz K; Sonabend RY; Scheurer ME; Paulino AC; Mahajan A; Chintagumpala M; Okcu MF; Brown AL
J Neurooncol; 2021 Oct; 155(1):93-100. PubMed ID: 34596831
[TBL] [Abstract][Full Text] [Related]
11. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
12. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
[TBL] [Abstract][Full Text] [Related]
13. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
Suzuki S; Kato T; Murakami M
J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
[TBL] [Abstract][Full Text] [Related]
14. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma.
Howell RM; Giebeler A; Koontz-Raisig W; Mahajan A; Etzel CJ; D'Amelio AM; Homann KL; Newhauser WD
Radiat Oncol; 2012 Jul; 7():116. PubMed ID: 22828073
[TBL] [Abstract][Full Text] [Related]
15. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.
Min CH; Paganetti H; Winey BA; Adams J; MacDonald SM; Tarbell NJ; Yock TI
Radiat Oncol; 2014 Nov; 9():220. PubMed ID: 25403752
[TBL] [Abstract][Full Text] [Related]
17. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
Paulino AC; Mahajan A; Ye R; Grosshans DR; Fatih Okcu M; Su J; McAleer MF; McGovern S; Mangona VA; Chintagumpala M
Radiother Oncol; 2018 Jul; 128(1):128-132. PubMed ID: 29373195
[TBL] [Abstract][Full Text] [Related]
18. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma.
Paulino AC; Suzawa HS; Dreyer ZE; Hanania AN; Chintagumpala M; Okcu MF
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):712-717. PubMed ID: 33516438
[TBL] [Abstract][Full Text] [Related]
19. Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers.
Taddei PJ; Khater N; Youssef B; Howell RM; Jalbout W; Zhang R; Geara FB; Giebeler A; Mahajan A; Mirkovic D; Newhauser WD
Biomed Phys Eng Express; 2018; 4(2):. PubMed ID: 30038799
[TBL] [Abstract][Full Text] [Related]
20. Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma.
Baroni LV; Freytes C; Fernández Ponce N; Oller A; Pinto N; Gonzalez A; Maldonado FR; Sampor C; Rugilo C; Lubieniecki F; Alderete D
J Neurooncol; 2021 Oct; 155(1):53-61. PubMed ID: 34505229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
